Sponsor:
Regeneron Pharmaceuticals
Code:
NCT03916627
Conditions
Non-small Cell Lung Cancer
Hepatocellular Carcinoma
Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
cemiplimab
Platinum Doublet
fianlimab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations